Investor Relations We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology. Email Alerts Investors: Overview Press Releases Events and Presentations Financials & Filings Stock Information Investor FAQs Contact Us Events Presentations 17th Annual Needham Healthcare Conference Wednesday, March 28, 2018 12:45pm - 1:45pm EDT Listen to the Webcast